SCHEMBL9154694

SCHEMBL9154694

COCCN1C(C)=C(C(=O)O)C(c2cccc(-c3nnc(C)o3)c2)C(C(=O)OC(C)C)=C1C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PYGM P11217 14/20 0.46
PYGL P06737 13/20 0.46
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 2/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9153388 0.80 PYGM (0.36) PYGMPYGLNPC1POLBRAB9A
SCHEMBL9153437 0.79 HTT (0.46) PYGMPYGLMEN1CYP1A2CYP3A4
SCHEMBL29926641 0.78 CYP1A2 (0.64) PYGMPYGLMEN1CYP1A2CYP3A4
SCHEMBL7400360 0.78 CYP1A2 (0.64) PYGMPYGLMEN1CYP1A2CYP3A4
SCHEMBL7448031 0.78 CYP1A2 (0.64) PYGMPYGLMEN1CYP1A2CYP3A4
SCHEMBL9153403 0.76 CTSA (0.37) SMN1; SMN2MEN1KMT2ALMNATSHR
SCHEMBL6949414 0.75 PYGM (0.49) PYGMPYGLMEN1KMT2A
SCHEMBL6953545 0.72 PYGM (0.49) PYGMPYGLMEN1KMT2A
SCHEMBL6947702 0.72 PYGM (0.53) PYGMPYGLKMT2A
SCHEMBL9156907 0.72 CA1 (0.42) PYGMPYGLNPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5403849-A Treatment of central nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1995-04-04 US claimed